-1722511478674.svg){kind=small}
Published 11:28 IST, October 1st 2024
Sun Pharma inks licensing pact with Philogen for cancer medication
As per the agreement, Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun, a speciality product of Philogen.
Sun Pharma will be responsible for commercialisation activities. | Image:
Sun Pharma
- Listen to this article
- 2 min read
Advertisement
11:28 IST, October 1st 2024